Received Feb 20, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z015274 | — |
No symptoms reported as of yet; the facility received the vaccine after the must be recieved by date and one dose was administered. The shipment had a must be received by date of 02/09/2026 and it was delivered on 02/10/2026.; This spontaneous report was received from a nurse and refers to a 4-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. The facility received the vaccine after the must be received by date. The shipment had a must be received by date of 09-Feb-2026 and it was delivered on 10-Feb-2026. On 10-Feb-2026, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Z015274, expiration date: 30-Mar-2027) (strength, dose, frequency, and anatomical location were not provided) for prophylaxis, diluted with sterile diluent (strength, dose, frequency, lot #, and expiration date were not reported) (Delayed dose administration). No symptoms were reported.
STERILE DILUENT